FXAIX
Price
$207.13
Change
+$3.26 (+1.60%)
Updated
Feb 28 closing price
Net Assets
632.47B
TICRX
Price
$22.33
Change
+$0.29 (+1.32%)
Updated
Feb 28 closing price
Net Assets
6.82B
Ad is loading...

FXAIX vs TICRX

Header iconFXAIX vs TICRX Comparison
Open Charts FXAIX vs TICRXBanner chart's image
Fidelity 500 Index
Price$207.13
Change+$3.26 (+1.60%)
VolumeN/A
Net Assets632.47B
Nuveen Large Cap Responsible Eq A
Price$22.33
Change+$0.29 (+1.32%)
VolumeN/A
Net Assets6.82B
FXAIX vs TICRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FXAIX vs. TICRX commentary
Mar 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a Buy and TICRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 632B vs. TICRX (6.82B). TICRX pays higher dividends than FXAIX: TICRX (1.38) vs FXAIX (1.31). FXAIX was incepted earlier than TICRX: FXAIX (14 years) vs TICRX (19 years). TICRX is a more actively managed with annual turnover of: 15.00 vs. FXAIX (3.00). FXAIX has a lower initial minimum investment than TICRX: FXAIX (0) vs TICRX (2500). FXAIX annual gain was more profitable for investors over the last year : 18.40 vs. TICRX (-5.02). FXAIX return over 5 years is better than : 117.83 vs. TICRX (37.34).
FXAIXTICRXFXAIX / TICRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years19 years-
Gain YTD1.4400.685210%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets632B6.82B9,272%
Annual Yield % from dividends1.311.3895%
Returns for 1 year18.40-5.02-366%
Returns for 3 years44.772.751,629%
Returns for 5 years117.8337.34316%
Returns for 10 years206.8450.39410%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APHKX49.930.25
+0.50%
Artisan International Value Instl
MERDX35.68N/A
N/A
Meridian Growth Legacy
ICTTX13.83N/A
N/A
ICON Health and Information Tech Inv
FDMLX10.64N/A
N/A
Fidelity Series Intrinsic Opps
CRMMX21.39N/A
N/A
CRM Mid Cap Value Inv